Characterization of neutralizing anti-pre-S1 and anti-pre-S2 (HBV) monoclonal antibodies and their fragments

Molecular Immunology

Volumn 36, Issue 10, 1999, Pages 669-683

  Kuttner G ^a   Kramer, A ^a   Schmidtke, G ^a   Giessmann, E ^a   Dong, L ^a   Roggenbuck, D ^a   Scholz, C ^a   Seifert, M ^a   Stigler, R D ^a   Schneider Mergener, J ^a   Porstmann, T ^a   Hohne W ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Antigen specificity; Epitope mapping; Fab; Flexible docking; Hepatitis B; Monoclonal antibody; Peptide library; Pre S1; Pre S2; scFv; Substitutional analysis

Indexed keywords

MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY;

ARTICLE; EPITOPE MAPPING; HEPATITIS B; HEPATITIS B VIRUS; HIGH RISK POPULATION; HUMAN; HUMAN CELL; MOLECULAR CLONING; MOLECULAR RECOGNITION; NUCLEOTIDE SEQUENCE; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; VIRUS CHARACTERIZATION; VIRUS NEUTRALIZATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; BASE SEQUENCE; DNA; EPITOPES, B-LYMPHOCYTE; GENE EXPRESSION; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HUMANS; IMMUNOGLOBULIN FRAGMENTS; MICE; MOLECULAR SEQUENCE DATA; NEUTRALIZATION TESTS; PEPTIDES; PROTEIN PRECURSORS;

EID: 0344200091     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(99)00074-7     Document Type: Article

References (60)

1. Abagyan R., Totrov M. Biased probability Monte Carlo conformational searches and electrostatic calculations for peptides and proteins. J. Mol. Biol. 235:1994;983-1002.
2. Abagyan R., Totrov M., Kuznetsov D. ICM - a new method for protein modelling and design: Applications to docking and structure prediction from the distorted native conformation. J. Comput. Chem. 15:1994;488-506.
3. Brooks B.R., Bruccoleri R.E., Olafson B.D., States D.J., Swaminathan S., Karplus M. CHARMM: a program for macromolecular energy, minimization and dynamics calculation. J. Comput. Chem. 4:1983;187-214.
4. Behar I., Padlan E.A., Jung S.H., Lee B., Pastan I. Rapid humanization of the Fv of monoclonal antibody B3 by using framework exchange of the recombinant immunotoxin B3(Fv)PE38. Proc. Natl. Acad. Sci. USA. 91:1994;12,051-12,055.
5. Chothia C., Lesk A.M. Canonical structures for the hypervariable regions of immunoglobulins. J. Molec. Biol. 196:1987;901-917.
6. Chothia C., Lesk A.M., Tramontano A., Levitt M., Smith-Gill S.J., Air G., Sheriff S., Padlan E.A., Davies D., Tulip W.R., Colman P.M., Spinelli S., Alzari P.M., Poljak R. Conformations of immunoglobulin hypervariable regions. Nature. 342:1989;877-883.
7. Clackson T., Hoogenboom H.R., Griffiths A.D., Winter G. Making antibody fragments using phage display libraries. Nature. 352:1991;624-628.
8. Coursaget P., Lesage G., Le Cann P., Mayelo V., Bourdil C. Mapping of linear B-cell epitopes of Hepatitis B surface antigen. Res. Virol. 142:1991;461-467.
9. D'Mello F., Partidos C.D., Steward M.W., Howard C.R. Definition of the primary structure of hepatitis B virus (HBV) pre S hepatocyte binding domain using random peptide libraries. Virology. 237:1997;319-326.
10. H genes used to produce idiotype posotive immunoglobulins. J. Immunol. 136:1986;1864-1870.
11. Evan G.I., Lewis G.K., Ramsay G., Bishop J.M. Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. Mol. Cell. Biol. 5:1985;3610-3616.
12. Frank R. Spot synthesis: an easy technique for the positionally addressable, parallel chemical synthesis on a membrane support. Tetrahedron. 48:1992;9217-9232.
13. Friguet B., Chaffotte A.F., Djavadi Ohaniance L., Goldberg M.E. Measurement of the true affinity constant in solution of antigen-antibody complexes by enzyme-linked immunosorbent assay. J. Immunol. Methods. 77:1985;305-319.
14. Gerlich W.H., Lu X., Heermann K-H. Studies on the attachment and penetration of Hepatitis B virus. J. Hepatol. 17:(suppl. 3):1993;S10-S14.
15. Germaschewski V., Murray K. Screening a monoclonal antibody with a fusion-phage display library shows a discontinuity in a linear epitope within pre-S1 of hepatitis B virus. J. Med. Virol. 45:1995;300-305.
16. Guidicelli V., Chaume D., Bodmer J., Müller W., Busin C., Mash S., Bontrop R., Mark L., Malik A., Lefranc M-P. IMGT, The International Immuno GeneTics database. Nucleic Acid Res. 25:1997;206-211.
17. Heermann K-H., Goldmann U., Schwartz U., Seyffarth T., Baumgarten H., Gerlich W.H. Large surface proteins of Hepatitis B virus containing the pre S sequence. J. Virol. 52:1984;396-402.
18. Holliger P., Prospero T., Winter G. 'Diabodies': Small bivalent and bispecific antibody fragments. Proc. Natl. Acad. Sci. USA. 90:1993;6444-6448.
19. Hooft R.W.W., Vriend G., Sander C., Abola E.E. Errors in protein structures. Nature. 381:1996;272.
20. Hoogenboom H.R., Griffiths A.D., Johnson K.S., Chiswell D.J., Hudson P., Winter G. Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains. Nucleic. Acids. Res. 19:1991;4133-4137.
21. Itoh Y., Takai E., Ohnuma H., Kitajima K., Tsuda F., Machida A., Mishiro S., Nakamura T., Miyakawa Y., Mayumi M. A synthetic peptide vaccine involving the product of the pre-S2 region of hepatitis B virus DNA: Protective efficacy in chimpanzees. Proc. Natl. Acad. Sci. USA. 83:1986;9174-9178.
22. Jones S.T., Bendig M.M. Rapid PCR-cloning of full-length mouse immunoglobulin variable regions. Biotechnol. 9:1991;88-89.
23. Kabat E.A., Wu T.T., Perry H.M., Gottesman K.S., Foeller C. Sequences of Proteins of Immunological Interest. 5th ed. 1991;Public Health Service, NIH, Washington DC.
24. Keitel T., Kramer A., Wessner H., Scholz C., Schneider-Mergener J., Höhne W. Crystallographic analysis of anti-p24 (HIV-1) monoclonal antibody cross-reactivity and polyspecificity. Cell. 91:1997;811-820.
25. Knappik A., Plückthun A. Engineered turns of a recombinant antibody improve its in vivo folding. Protein Eng. 8:1995;81-89.
26. Kramer A., Schneider-Mergener J. Synthesis of peptide libraries on continuous cellulose membranes. Meth. Mol. Biol. 87:1998;25-39.
27. Küttner G., Keitel T., Gießmann E., Wessner H., Scholz C., Höhne W. A phage library-derived single-chain Fv fragment in complex with turkey egg white lysozyme: Characterization, crystallization and preliminary X-ray analysis. Mol. Immunol. 35:1998;189-194.
28. Kuroki K., Floreani M., Mimms M., Ganem D. Epitope mapping of the pre-S1 domain of the Hepatitis B virus large surface protein. Virology. 176:1990;620-624.
29. Lee M.K., Kim K.L., Hahm K.S., Yang K.H. Structure-antigenicity relationship of peptides from the pre-S2 region of the Hepatitis B virus surface antigen. Biochem. Mol. Biol. Int. 34:1994;159-168.
30. Lee M.K., Kim K.L., Hahm K.S. Epitope mapping of pre-S2 of the hepatitis B virus surface antigen against a conformation-dependent monoclonal antibody using synthetic peptides. Biochem. Mol. Biol. Int. 40:1996;1077-1085.
31. Lee M.K., Kim K.L., Hahm K.S. Evaluation of the N-terminal role in peptide antigenicity of the pre-S2 region of the hepatitis B virus surface antigen. Mol. Cells. 7:1997;340-346.
32. Mackenzie C.R., Hirama T., Deng S.J., Bundle D.R., Narang S.A., Young N.M. Analysis by surface plasmon resonance of the influence of valence on the ligand binding affinity and kinetics of an anti-carbohydrate antibody. J. Biol. Chem. 271:1996;1527-1533.
33. Mimms M., Floreani M., Tyner J., Whitters E., Rosenlof R., Wray L., Goetze A., Sarin V., Eble K. Discrimination of Hepatitis B virus (HBV) subtypes using monoclonal antibodies to the pre-S1 and pre-S2 domains of the viral envelope. Virology. 176:1990;604-619.
34. Neurath A.R., Kent S.B.H., Strick N., Taylor P., Stevens C.E. Hepatitis B virus contains pre S gene-encoded domains. Nature. 315:1985;154-156.
35. Neurath A.R., Kent S.B.H., Parker K., Prince A.M., Strick N., Brotman B., Sproul P. Antibodies to a synthetic peptide from the pre-S120-145 region of the Hepatitis B envelope are virus neutralizing. Vaccine. 4:1986;35-37.
36. Neurath A.R., Strick N., Kent S.B.H., Parker K., Seto B., Girard M. Design of synthetic peptides mimicking the immunologic and biologic functions of the pre-S1 sequence of the Hepatitis B virus envelope protein. Ginsberg H., Brown F., Lerner R.A., Chanak R.M. Vaccines 88. 1988;229-234 Cold Spring Harbour Laboratory, Cold Spring Harbour.
37. Neurath A.R., Seto B., Strich N. Antibodies to synthetic peptides from the pre-S1 region of the Hepatitis B virus envelope are virus-neutralizing and protective. Vaccine. 7:1989;234-236.
38. Orlandi R., Güssow D.H., Jones P.T., Winter G. Cloning immunoglobulin variable domains for expression by the polymerase chain reaction. Proc. Natl. Acad. Sci. USA. 86:1989;3833-3837.
39. Park S.S., Ryu C.J., Gripon P., Guguen-Gillouzo C., Hong H.J. Generation and characterization of a humanized antibody with specificity for pre-S2 surface antigen of hepatitis B virus. Hybridoma. 15:1996;435-441.
40. Petit M-A., Dubanchet S., Capel F., Voet P., Dauguet C., Hauser P. Hep G2 cell binding activities of different hepatitis B virus isolates: inhibitory effect of anti-Hbs and anti-pre-S1(21-47). Virology. 180:1991;483-491.
41. Pontisso P., Petit M-A., Bankowski M.J., Peeples M.E. Human liver plasma membranes contain receptors for the Hepatitis B virus pre-S1 region and, via polymerized human serum albumin, for the pre-S2 region. J. Virol. 63:1989;1981-1988.
42. Pontisso P., Ruvoletto M.G., Gerlich W.H., Heermann K-H., Bardini R., Alberti A. Identification of an attachment site for human liver plasma membranes on Hepatitis B virus particles. Virology. 173:1989;522-530.
43. Prange R., Werr M., Birkner M., Hilfrich R., Streeck R.E. Properties of modified hepatitis B virus surface antigen particles carrying pre S epitopes. J. Gen. Virol. 76:1995;2131-2140.
44. Rheinnecker M., Hardt C., Ilag L.L., Kufer P., Gruber R., Hoess A., Lupas A., Rottenberger C., Plückthun A., Pack P. Multivalent antibody fragments with high functional affinity for a tumor-associated antigen. J. Immunol. 157:1996;2989-2997.
45. Roguska M.A., Pedersen J.T., Keddy C.A., Henry A.H., Searle S.J., Lambert J.M., Goldmacher V.S., Blattler W.A., Rees A.R., Guild B.C. Humanization of murine monoclonal antibodies through variable domain surfacing. Proc. Natl. Acad. Sci. USA. 91:1994;969-973.
46. Ryu C.J., Gripon P., Park S.S., Kim Y.K., Guguen-Gillouzo C., Yoo O.J., Hong H.J. In vitro neutralization of hepatitis B virus by monoclonal antibodies against the viral suface antigen. J. Med. Virol. 52:1997;226-233.
47. Sanger F., Nicklen S., Coulson A.R. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA. 74:1977;5463-5467.
48. Seligman S.J. Influence of solid-phase antigen in competition enzyme-linked immunosorbent assays (ELISAs) on calculated antigen-antibody dissociation constants. J. Immunol. Methods. 168:1994;101-110.
49. Sominskaya I., Pushko P., Dreilina D., Kozlovskaya T., Pumpens P. Determination of the minimal length of Pre-S1 epitope recognized by a monoclonal antibody which inhibits attachment of Hepatitis B virus to hepatocytes. Med. Microbiol. Immunol. 181:1992;215-226.
50. Sominskaya I., Bichko V., Pushko P., Dreimane A., Snikere D., Pumpens P. Tetrapeptide QDPR is a minimal immunodominant epitope within the pre-S2 domain of Hepatitis B virus. Immunol. Lett. 33:1992;169-172.
51. Stanfield R.L., Fieser T.M., Lerner R.A., Wilson I.A. Crystal structures of an antibody to a peptide and its complex with peptide antigen. Science. 248:1990;712-719.
52. Stibbe W., Gerlich W.H. Variable protein composition of Hepatitis B surface antigen from different donors. Virology. 123:1982;436-442.
53. Stibbe W., Gerlich W.H. Structural relationships between minor and major proteins of Hepatitis B surface antigen. J. Virol. 46:1983;626-628.
54. Tiollais P., Buendia M-A. Hepatitis B virus. Sci. Am. 264:1991;48-54.
55. Vriend G. WHAT IF: a molecular modelling and drug design program. J. Mol. Graph. 8:1990;52-56.
56. Vulliez-le-Normand B., Saul F.A., Martineau P., Lema F., Hofnung M., Bentley G.A. Maltodextrin-binding protein hybrids carrying epitopes from the pre-S2 region of hepatitis B virus: expression, antibody-binding and preliminary crystallographic studies. Protein Eng. 10:1997;175-180.
57. Whitlow M., Filpula D., Rollence M.L., Feng S.L., Wood F. Multivalent Fv's - characterization of single-chain Fv oligomers and preparation of a bispecific Fv. Prot. Eng. 7:1994;1017-1026.
58. Wilson I.A., Stanfield R.L., Rini J.M., Arevalo J.H., Schulze-Gahmen U., Fremont D.H., Stura E.A. Catalytic antibodies. Ciba Foundation Symposium 159. 1991;13-39 Wiley, Chichester.
59. Zauhar R.J., Morgan R.S. A new method for computing the macromolecular electric potential. J. Mol. Biol. 186:1985;815-820.
60. Zhou H., Fisher R.J., Papas T.S. Optimization of primer sequences for mouse scFv repertoire display library construction. Nucleic Acids Res. 22:1994;888-889.